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CRISPR/Cas9 technologies have been employed for genome editing to achieve gene knockouts and
knock-ins in somatic cells. Similarly, certain endogenous genes have been tagged with fluorescent proteins.
Often, the detection of tagged proteins requires high expression and sophisticated tools such as confocal
microscopy and flow cytometry. Therefore, a simple, sensitive and robust transcriptional reporter system
driven by endogenous promoter for studies into transcriptional regulation is desirable. We report a
CRISPR/Cas9-based methodology for rapidly integrating a firefly luciferase gene in somatic cells under
the control of endogenous promoter, using the TGFb-responsive gene PAI-1. Our strategy employed a
polycistronic cassette containing a non-fused GFP protein to ensure the detection of transgene delivery and
rapid isolation of positive clones. We demonstrate that firefly luciferase cDNA can be efficiently delivered
downstream of the promoter of the TGFb-responsive gene PAI-1. Using chemical and genetic regulators of
TGFb signalling, we show that it mimics the transcriptional regulation of endogenous PAI-1 expression.
Our unique approach has the potential to expedite studies on transcription of any gene in the context of its
native chromatin landscape in somatic cells, allowing for robust high-throughput chemical and genetic
screens.
T ranscriptional reporters using firefly luciferase and green fluorescent protein (GFP) have been extensivelyexploited to investigate the function and regulation of transcription factors. These reporters provide a robusttool for high throughput genetic and drug discovery screens1,2. Conventional reporters were constructed on
a cDNA expression vector carrying either a promoter fragment or repeats of specific nucleotide sequences. In both
cases, the DNA sequences are designed to recruit their cognate transcription factors followed by a minimal promoter
and a gene, such as luciferase, beta lactamase or a fluorescent protein, which is used as a functional readout.
In contrast, endogenous gene promoters are positioned in a unique chromatin landscape and contain binding
sites for enhancers, repressors and other cofactors, which may be located far away from the promoter3-6. As
conventional transcriptional reporters contain only a fragment of the promoter region, they critically lack the
chromatin context and regulatory components of the transcriptional machinery. Often they also exclude the post-
transcriptional regulatory elements that exist within the non-coding regions of the mRNAs7. Ideally a reporter
system should engage all components of an endogenous gene regulation, including the native chromatin archi-
tecture.We have achieved this by using CRISPR/Cas9 genome engineering technology8-12 to integrate a luciferase
andGFP reporter cassette directly downstream of the endogenous promoter of a transforming growth factor-beta
(TGFb) responsive gene PAI-1 (plasminogen activator inhibitor-1)13. TGFb, through SMAD-transcription fac-
tors, potently induces the expression of PAI-1 transcript in many cells. Consequently, the SMAD-binding region
of the PAI-1 promoter has been frequently exploited to design the conventional TGFb-responsive luciferase
reporter systems13. PAI-1 protein plays a critical role in the regulation of fibrinolysis by inhibiting the tissue-type
and urokinase-type plasminogen activators. Polymorphisms on the PAI-1 promoter region that cause enhanced
expression are associated with an increased risk of thrombosis and cancer14,15. Elevated levels of PAI-1 have also
been linked to fibrotic lung disorders and development of diabetic nephropathy16. In contrast, decreased PAI-1
expression has been associated with lifelong bleeding disorder17.
The CRISPR/Cas9 genome-editing system relies on the induction of a double-strand break at the























complementarity between the engineered sgRNA and its target geno-
mic DNA sequences8-12. The CRISPR/Cas9 methodology has been
used for the generation of gene knockouts and knock-ins in cells
derived from a multitude of species including human, rats, mice,
zebrafish, drosophila, nematodes and the parasite Plasmodium
yoelii 18-30. In some cases, fluorescent proteins such as GFP have been
used for the characterisation and quantification of homologous
recombination events as well as for endogenous gene-tagging and
determination of subcellular localisation of expressed proteins.31 As
the detection of any fluorescent protein relies on the levels of express-
ion, low to very low levels of fluorescent tagged proteins driven by
endogenous promoters can be challenging to detect even with soph-
isticated tools such as confocal microscopy or flow cytometry.
Results
In order to generate a sensitive transcriptional reporter capable of
being exploited for high throughput screens, we used a firefly luci-
ferase cassette downstream of the endogenous promoter of the PAI-1
gene. We took advantage of the non-tagged GFP downstream of
luciferase to ensure fluorescence-based detection of the cassette
delivery and isolation of luciferase positive clones. Using recently
developed super-efficient CRISP/Cas9 system in a doxycycline-
inducible osteosarcoma U2OS Stably Expressing Cas9-Cells (SEC-
C),32 we co-transfected a vector encoding sgRNA targeting the start
codon region of the PAI-1 gene (sgPAI-1) together with the TGFb
reporter donor vector containing two homologous regions
(,500nts) with the PAI-1 gene, one upstream (L-Arm) and one
downstream (R-Arm) of the luciferase and GFP reporter cassette,
to allow for homologous recombination (Fig. 1a). To ensure the
integrity of the R-Arm, we introduced silent mutations on the
sgPAI-1 recognition site. The reporter cassette in the donor vector
encodes the firefly luciferase enzyme cDNA, which following homo-
logous recombination overlaps perfectly with the start codon (ATG)
of the endogenous PAI-1 gene (Fig. 1a). Directly downstream of the
luciferase gene, we incorporated an IRES-GFP-2a cassette. The IRES
element ensures the expression of GFP separately from the luciferase
protein, while the 2a self-cleaving peptide ensures the cleavage of the
Figure 1 | The development of an endogenously driven, second-generation luciferase and GFP reporter for the TGFb pathway (2G TGFb reporter).
a. An outline of the strategy used to generate the 2G TGFb reporter targeting the PAI-1 gene locus. b. Relative expression levels of PAI-1 mRNA in WT
U2OS cells stimulated with TGFb by qRT-PCR. c.Western blotting of WT U2OS cells stimulated with TGFb. d. U2OS(SEC-C) control and transfected
(sgPAI-1 and the 2G TGFb reporter donor vector) cells were analysed for GFP expression using FACS. e. Luciferase activity of GFP-expressing single cell
clones was measured. f. Distribution of GFP fluorescence intensity in 2G TGFb reporter cells before and after TGFb stimulation. g. Wide field
fluorescence microscopy imaging of GFP expression in 2G TGFb reporter cells treated without or with TGFb. Scale bars represent 20 mm. GFP channel
indicated in green and nuclear DAPI staining in blue. h. EtBr-stained agarose gel showing PCR products of genomic DNA samples of U2OS(SEC-C)
control and 2GTGFb reporter (clone-17) cells. PCR products (of Allele-1) were isolated, cloned and sequenced. Clone-17 shows a frame shift insertion as
indicated in chromatograms. Bar chart data are represented as mean and error bars indicate standard deviation.
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GFP protein from the endogenous PAI-1 further downstream, both
in frame. We call this unique targeting strategy: the second-genera-
tion reporter (2G-reporter) system (Fig. 1a).
Using the U2OS parental cells, we demonstrate that the expression
of both the PAI-1 transcript (Fig. 1b) and protein (Fig. 1c) are
enhanced upon stimulation with TGFb for up to 24h over basal
levels. Following the transfection of U2OS (SEC-C) with sgPAI-1
and the 2G TGFb donor vector, Cas9 expression was induced by
doxycycline. After seven days, control or transfected cells were ana-
lysed by flow-cytometry (FACS) for GFP expression. Approximately
1% of the sgPAI-1 and 2G-donor transfected cell population exhib-
ited GFP expression (Fig. 1d), indicating the integration of the
2G-reporter cassette. The efficiency of the homologous recombination
is dependent on many factors, however using the U2OS SEC-C cells
can yield efficiency as high as 13%, as we observed for the YFP in situ
tagging of the Histone 3 Chaperone Chaf1a (Supplementary Fig. 4).
Single cells of the TGFb 2G-donor GFP-expressing cells were
transferred onto 96-well plates and allowed to proliferate. Of the first
33 clones tested for TGFb responsiveness, 30 showed enhanced luci-
ferase activity over control cells, with 28 clones showing significant
induction of luciferase activity upon TGFb treatment. Highly
responsive clones were selected for further analyses (Fig. 1e). As
the GFP gene is further downstream from luciferase within the
2G-donor cassette, the GFP expression in response to TGFb was
confirmed in clone-17 by measuring the percentage of maximum
fluorescence in a histogram (Fig. 1f) and by fluorescence microscopy
(Fig. 1g). In order to determine the genotype of the 2G-reporter
clones, we amplified the genomic region of the PAI-1 gene with
Figure 2 | Functional characterisation of the 2G TGFb reporter cells. a. U2OS(SEC-C) and 2G TGFb reporter cells were stimulated with TGFb
for the indicated time points and lysed. The extracts were resolved and immunoblotted with the indicated antibodies. b. U2OS(SEC-C) and 2G TGFb
reporter cells were stimulated with TGFb for the indicated times and the relative expression of PAI-1 mRNA analysed by qRT-PCR. c. 2G TGFb reporter
cells were left untreated or treated continuously with TGFb for the indicated time points prior to lysis and luciferase activitymeasured. d.Apulse of TGFb
treatment for 1h was applied to 2G TGFb reporter cells and upon TGFb removal, cells were lysed at the indicated times and the luciferase activity
measured. e. 2G TGFb reporter cells were treated with or without TGFb and with or without the type I TGFb receptor inhibitor SB505124. f. 2G TGFb
reporter cells were transfected with siRNAs against non-targeting control (siNT), TGFbR2 or SMAD4. Cells were treated with SB505124 and/or TGFb as
indicated prior to lysis and luciferase activity measured. g. Luciferase activity of 2G TGFb reporter cell extracts following transfection with vectors
encoding the LacI DNA binding domain control or Flag-tagged SMAD3 (1mg per well of 12 well plates). h. 2G TGFb reporter cells were stimulated with
50pM TGFb, 50ng/ml EGF or 10 ng/mL PMA for 20h, in the presence or absence of TGFb pathway inhibitor SB505124, prior to lysis and extracts were
subjected to luciferase activity measurements. Bar chart data are represented as mean and error bars indicate standard deviation.
www.nature.com/scientificreports
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primers located outside of the homologous recombination arms
(Supplementary Fig. 1a). All clones in this study were heterozygotes,
with only one copy of the 2G-reporter cassette inserted into one of
the alleles of the PAI-1 gene (Supplementary Fig. 1b). We also
addressed whether the other allele was functional, by cloning the
shorter amplified fragment from several clones and sequencing
(Fig. 1I and Supplementary Fig. 1c). We found that the non-
2G-reporter integrated alleles of PAI-1 gene were also disrupted in
all TGFb-responsive clones, including clone-17 in which there was
an insertion of a single nucleotide (Fig. 1I and Supplementary Fig.
1c). Furthermore, a Southern blot analysis using a digoxigenin-
labeled probe against the firefly Luciferase cDNA revealed a single
genomic integration of the 2G donor cassette in the clone-17
(Supplementary Fig. 1E & 1F).
Next, we investigated the impact of TGFb signalling on transcrip-
tion at the PAI-1 gene locus upon integration of the 2G-reporter
cassette. In U2OS(SEC-C) control cells, a time course of TGFb
induces the phosphorylation of SMAD2 (Fig. 2a). In U2OS
2G-reporter cells (clone-17), a time course of TGFb induces similar
levels of phospho-SMAD2, while GFP expression is also induced in a
time-dependent manner (Fig. 2a). In these cells, as one allele of the
PAI-1 gene is affected by the integration of the 2GTGFb reporter and
the insertion of a single nucleotide on other allele causes a frame-shift
mutation, lower basal levels of PAI-1 mRNA are observed in com-
parison to U2OS(SEC-C) control cells (Supplementary Fig. 1d).
Nonetheless, TGFb induces the expression of PAI-1 transcripts in
both U2OS(SEC-C) control and 2G-reporter cells (clone-17) in ana-
logous manner over time (Fig. 2b).
A time course of sustained TGFb activation of the 2G-reporter
cells results in a time-dependent increase in luciferase activity
(Fig. 2c). On the other hand, when cells exposed to a single pulse
of TGFb for 1h were lysed at various time points thereafter, the
luciferase activity increased with time until it peaked at 12h and
dropped significantly after 24h (Fig. 2d). Although TGFb stimu-
lation of the 2G-reporter cells induces robust luciferase activity
and GFP fluorescence, basal detectable levels of luciferase activity
and GFP expression were consistently observed under normal
growth conditions. This allowed the selection of positive clones in
the initial steps by cell sorting. We hypothesized that a portion of the
basal levels of GFP expression and luciferase activity was the result of
autocrine TGFb signalling. Consistent with this notion, treatment of
cells with SB505124, a selective inhibitor of TGFb type I receptors,
strongly inhibited the basal levels of luciferase activity (Fig. 2e). As
expected, SB505124 also inhibited TGFb-induced luciferase activity
(Fig. 2e). In summary, our data demonstrates that the TGFb-induced
luciferase activity and GFP expression in 2G-reporter cells mirrors
that of TGFb-induced PAI-1 expression in other cells. Therefore, the
2G-reporter cells could be exploited as powerful tools to perform
genetic and chemical screens for the identification of regulators of
TGFb signalling. As a proof-of-principal analysis, we demonstrate
that siRNA-mediated ablation of TGFBR2 and SMAD4, which are
both key transducers of TGFb signals in cells, from 2G-reporter cells
results in a decrease in both basal and TGFb-induced luciferase
activity (Fig. 2f and Supplementary Fig. 2a). On the other hand,
overexpression of SMAD3, which mediates TGFb signalling in most
cells, resulted in enhanced basal and TGFb-induced luciferase activ-
ity (Fig. 2g and Supplementary Fig. 2b).
In addition to the SMAD transcription factors downstream of
TGFb signalling, the PAI-1 promoter is reported to be regulated
by several other transcription factors such as AP-1, AP-2, SP1,
CTF/NF1, p53 and Elk-133. The 2G TGFb reporter cell line allows
for the investigations into how PAI-1 gene expression is regulated in
response to unique environmental and metabolic signals. Indeed, we
demonstrate that the treatment of 2G reporter cells with either epi-
dermal growth factor (EGF), which activates the MAPK pathway, or
Phorbol 12-myristate-13-acetate (PMA), which activates AP-1
through the JNK pathway, resulted in a significant increase in luci-
ferase activity independently of TGFb signalling (Fig. 2h and
Supplementary Fig. 2c).
Conclusions
We describe an efficient methodology for the generation of an endo-
genously driven luciferase reporter at the PAI-1 gene locus in U2OS
cells through the exploitation of CRISPR/Cas9 gene-editing techno-
logy. Our methodology can be exploited to rapidly integrate similar
reporters on any basally or inducibly expressed genes by incorporat-
ing a fluorescent protein into a polycistronic donor cassette. Our
approach using U2OS SEC-C cells allows for a highly efficient tar-
geting of any endogenous gene32. In our system, the expression of
Cas9 is induced directly after transfection of sgRNA by adding dox-
ycycline. The Cas9/sgRNA-activated nuclease is further targeted to
the cognate locus, thereby catalysing a DNA double strand break. In
the absence of a donor vector, cells either repair this break normally
or by introducing nucleotide deletions or insertions that may cause
frame-shift on the gene of interest, potentially resulting in a gene
knockout. In the U2OS SEC-C cells, even if the gene is repaired
properly after the first break, as long as the Cas9/sgRNA are still
active and present, they will continually induce breaks at the locus.
Thus, we introduced a negative selection for proper repair. By adding
a donor vector, we induced a homologous recombination to integrate
the polycistronic cassette at the correct locus.
In exploiting our approach further, we have identified key factors
that play important roles in determining the efficiency of homolog-
ous recombination. Firstly, the nature of the gene is a major factor -
we observed that when we rescue the expression of an essential gene
targeted by CRISPR/Cas9 by co-transfecting a donor cassette, the
efficiency increases. An example is shown in the Supplementary
Fig. 4, where we endogenously tagged the essential Histone H3 cha-
perone Chaf1a with a yellow fluorescent protein (YFP). The effi-
ciency of YFP positive cells was over 13% compared to 1% for the
PAI-1 locus. 100% of the YFP-positive cells showed at least one
Chaf1a allele tagged with YFP. Furthermore,,1% YFP-positive cells
exclusively expressed the Chaf1a-YFP fusion protein indicating the
presence of homozygous integration, where both alleles have been
tagged. This data confirms that U2OS SEC-C cell line is a good
system for using CRISPR/Cas9 technology not only for gene knock-
outs but also for knock-ins. Secondly, as has been previously
reported, the homogeneity of the Cas9 nuclease expression also plays
an important role in the efficiency of cleavage and hence that of
homologous recombination32 in U2OS SEC-C cells, in which Cas9
expression is isogenically expressed by doxycycline. Thirdly, the
properties of sgRNA also play an important role in determining
the efficiency of recombination. We observed that different sets of
gRNAs targeting the proximal regions of a gene transfected under
identical circumstances resulted in different efficiencies of homolog-
ous recombination (data not shown).
The expression of GFP in our system allowed us to select positive
clones through flow cytometry, allowing us to enrich for target cells
even though the efficiency of the integration was low. It is conceiv-
able that the insertion of an IRES results in a moderate alteration in
expression of the target gene. Therefore, when a 2G reporter is used,
we suggest choosing a gene that is unlikely to affect cellular physi-
ology when its expression is moderately altered. In the case of PAI-1
gene, the protein product is secreted to the extracellular matrix,
where it plays a key role in fibrinolysis but does not impact the
physiology of the cells producing it. In our experiments with the
polycystronic cassette, ,85% of the single isolated GFP positive
clones also displayed significantly elevated luciferase activity upon
TGFb treatment, suggesting efficient integration of the cassette at the
target locus. Considering that in the absence of GFP co-expression
the generation of a luciferase reporter would be very laborious, we
consider our system efficient and rapid. In mammalian cell lines,
www.nature.com/scientificreports
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targeting of a second-generation reporter should take less than 3 weeks
(Supplementary Fig. 3). In summary, ourmethodology can be exploited
in gene editing strategies in cells by replacing the endogenous genes at
the start codonwith luciferase and fluorescent proteins, which allows for
rapid selection of positive clones through FACS sorting. Remarkably the
luciferase-based reporters do not require sophisticated instruments
for detection and provide a sensitive and quantitative detection of
transcription for high-throughput as well as small-scale experiments.
Using our system, we were able to verify the relative TGFb-dependent
and independent expression of PAI-1 in cells.
Methods
Construction of a second generation Luciferase and GFP reporter for genome
editing at the PAI-1 locus with CRISPR/Cas9. Analysis of the N-terminal coding
region of PAI-1/SERPINE1 (ensembl ENSG00000106366) revealed a number of
potential Cas9 guide sites in exon 2, which were identified as demonstrating high
target affinity, high efficiency and a low off-target scores using the E-CRISPR software
(http://www.e-crisp.org/E-CRISP/reannotate_crispr.html). The optimal scoring
guide target site GCACCATCCCCCATCCTACG[TGG] (corresponding to
nucleotides 72-94 of PAI-1 NM_000602.4, PAM site in brackets) was chosen to
perform the CRISPR gene-editing using wild-type Cas9. This sequence was cloned
into pESgRNA via site-directed mutagenesis using the QuickChange method
(Stratagene) in conjunction with KOD Hot Start DNA polymerase (Novagen) and
sequence verified (pESgPAI-1 vector)32.
An N-terminal donor was designed around the point of Cas9 cleavage site to
replace the ATG start codon of PAI-1 with a polycistronic insert consisting of a
Luciferase-hPEST-IRES2-GFP-2A cassette surrounded by 500 bp flanking homology
arms to the locus. The insert was designed to remain in-frame with PAI-1 and the use
of IRES and 2A elements would ensure the expression of both the luciferase and GFP
reporters as well as the native PAI-1 gene as separate proteins. Additional silent
mutations were engineered to the guide region to ensure the donor was not open to
attack by the Cas9 nuclease. This second generation TGFb reporter donor (2G TGFb
reporter) was synthesized by GeneArt (Life Technologies) (Supplementary Figure 2).
All the reagents and cell lines used in this study are available to request from the
MRC-PPU Reagents Page (https://mrcppureagents.dundee.ac.uk).
Transfection of guide RNA and donor vector into U2OS SEC-C cells.AU2OS Flp-
In T-REx cell line has been stably transfected with a pcDNA5 FRT-TO-Cas9-Flag
vector and further selected for an isogenic population under hygromycin selection.
The U2OS Stably Expressing Cas9 Cell line (SEC-C) has resulted in highly efficient
Cas9-induced double strand breaks and the generation of knockout cell lines32. We
exploited the U2OS SEC-C for the generation of the 2G TGFb reporter. 1x105 U2OS
SEC-C Cas9-Flag cells were co-transfected with 3 mg of pESgPAI-1 and 3mg L-ARM
(Luciferase-hPEST-IRES2-GFP-2A) R-ARM donor vectors using Lipofectamine
2000, according to themanufacturer’s instructions.Next, cells were incubated for 12 h
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 2mML-glutamine, 100mg/ml transfection compatible antibiotic
NormocinTM (Invivogene). The medium was then replaced by fresh medium
supplemented with 2 mg/ml doxycycline to induce Cas9 expression and cells were
incubated for an additional 24 h. To increase the efficiency of homologous
recombination, a repeat transfection on the same cells following identical procedure
was carried out and cells were maintained in medium supplemented with
2 mg/ml doxycycline for 7 days, with fresh medium replaced every two days.
Flow cytometry and cell sorting.Cells were analysed for GFP fluorescence on an LSR
Fortessa or FACS Canto flow cytometer (Becton Dickinson) and data analysed using
FlowJo software (Tree Star Inc). Single cells were identified on the basis of FSC-A, FSC-W
andSSC-AandGFP fluorescencemeasuredwith 488nmexcitation and emission detected
at 530 6 30 nm. Cell sorting was performed on an Influx cell sorter (Becton Dickinson)
with FACS Sortware, using the same cell identification procedure as described above.
Single GFP expressing cells were sorted onto individual wells of a 96 well plate
containingDMEMsupplementedwith 20% fetal bovine serum (FBS), 2mML-glutamine,
100 units/ml penicillin and 100 mg/ml streptomycin and 100 mg/ml transfection
compatible antibiotic NormocinTM (Invivogene). Single cell clones were allowed to
proliferate and analysed for luciferase activity and GFP fluorescence as described below.
Cell culture, stimulation and lysis. U2OS cells were cultured in DMEM
supplemented with 10% FBS, 2 mM L-glutamine, 100 units/ml penicillin and
100 mg/ml streptomycin. Cells were maintained at 37uC in a humidified atmosphere
with 5% CO2. Human recombinant TGFb1 (R&D Systems) was diluted in a solution
containing 4 mMHCl and 0.1% BSA. Cells were serum starved for 16 h at 37uC prior
to treatment with TGFb1 (50 pM) for the indicated times prior to lysis. Cell lysis for
immunoblotting applications was performed by washing cells once in 1 x PBS and
scrapping on ice in lysis buffer (50 mM Tris/HCl pH 7.5, 0.27 M sucrose, 150 mM
NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM sodium orthovanadate, 1 mM sodium
b-glycerophosphate, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1%
Triton X-100, 0.5% Nonidet P-40) supplemented with complete protease inhibitors
(1 tablet per 25 ml) and 0.1% b-mercaptoethanol. Extracts were centrifuged for
10 min at 4uC, 14000 rpm and processed immediately or snap frozen in liquid
nitrogen and stored at -80uC. The protein concentration was determined using
the Bradford method34. siRNA SMARTpool On-Target plus mix (Dharmacon)
of 4 siRNA oligos were used for knockdown experiments: non-targeting pool siNT
(D-001810-10), TGFBR2 (LU-003930), SMAD2 (LU-003561) and SMAD4
(LU-003902). siRNA transfections were performed using Lipofectamine RNAiMax
according to themanufacturer’s instructions. For mRNA isolation, cells were
processed using an RNA extraction kit according to the manufacturer’s instructions
(Qiagen RNeasy kit).
Luciferase assay. For luciferase assays, cells were lysed, after washing twice with 1xPBS,
by adding passive lysis buffer (Promega) directly onto the plates following the
manufacturer’s protocol. Extracts were collected and centrifuged at 14000 rpm for
5 min. 50 ml of cleared extract was transferred into each well of a 96 well plate (#655083,
Greiner Bio-one) containing 50 ml of 2 x Luciferase Buffer (50 mM Tris/phosphate
(pH7.8), 16mMMgCl2, 2mMDTT (dithiothreitol), 30% (v/v) glycerol, 1mMATP, 1%
BSA, 0.25 mM luciferin and 8 mM sodium pyrophosphate) and the data was obtained
using anEnvision2104plate reader (PerkinElmer). Protein concentration, determinedby
BCA Protein Assay Reagent (Pierce), was used for data normalisation.
Microscopy.Cells were plated on 12mm coverslips. After TGFb treatment, cells were
fixed for 10 min in 3.7% formaldehyde at room temperature for 20 min and
permeabilised with 0.2%Triton X-100 for 5min. Next, cells were washed 3 times with
PBS and incubated for 5 min with 0.1 mg/ml DAPI. Finally, the coverslips were
washed 3 times with PBS, twice with water and once with ethanol, before mounting
them ontomicroscope slides with Vectashield (Vector H-1000). Cells were imaged on
aDeltaVision Spectris wide fieldmicroscope fitted with a 37uC environment chamber
(Solent Scientifi c, Segensworth, United Kingdom).
Genomic sequencing. Genomic DNA from U2OS SEC-C and 2G TGFb reporter
single cell clones were isolated using DNeasy Blood & Tissue Kit (Qiagen). Genomic
DNA was amplified by PCR using KOD Hot Start DNA Polymerase (Novagen).
Primers used are as follows (59-39): PAI-1 genomic forward:
CGCTGGGAAAGCATTAAGAG and PAI-1 genomic reverse:
GAACTCCTAGCCTTGGGTGA. The PCR products were separated by size in 1%
agarose gels. Genomic PCR of single cell clones positive for the 2G TGFb reporter
insertion by homologous recombination resulted in the amplification of a large PCR
product of 5021 nucleotides (Allele-2) corresponding to the 2G TGFb reporter
insertion and a small fragment of 1850 nucleotides (Allele-1) corresponding to the
non-recombined allele. The small PCR product of control and 2G reporter single cell
clones were isolated with a gel extraction kit (Qiagen) and cloned into pSC-B-amp/
kan Vector by using StrataClone Blunt PCR Cloning Kit (Agilent Technologies). For
each genomic PCR cloning reaction, 20 positive colonies (white colonies) were
amplified and DNA isolated by the DNA prep service at the Division of Signal
Transduction Therapy (DSTT) at the University of Dundee. The cloning of genomic
PCR fragments allows for the isolation and sequencing of the single DNA molecules
corresponding to each allele. This procedure ensures the characterisation of the
genotype of both alleles and avoids the possibility of cellular trisomy.We sequenced at
least 20 clones of control and 2GTGFb reporter isolated single cell lines. Primers used
are as follows (59-39): AR906 forward: CACCTGCTTTTCTTCTAAGG and AR907
reverse: GGGAAGGGAGATGGACTGG.
Real time quantitative reverse transcription PCR (qRT-PCR). qRT-PCR
experiments were performed as previously described35,36. Cells were seeded onto 6-
well plates, serum starved for 16 h prior to TGFb1 (50 pM) treatment. cDNA was
made from 1 mg of the isolated RNA using the I-Script cDNA kit (BioRad) according
to the manufacturer’s protocol. qRT-PCR reactions were performed in quadruplicate
according to the manufacturer’s protocol in a CFX 384 Real time System qRT-PCR
machine (BioRad). Each reaction included cDNA (2.5% of reverse transcriptase
reaction) with forward and reverse primers (0.5 mM each) and 50% SYBR Green
(BioRad). All primers were designed using PerlPrimerH and purchased from
Invitrogen. Primers used are as follows (59-39): PAI-1 forward: AGCTCCTTGTAC-
AGATGCCG, reverse: ACAACAGGAGGAGAAACCCA, GAPDH forward:
TGCACCACCAACTGCTTAGC, reverse: GGCATGGACTGTGGTCATGAG,
RPL13A forward: CCTGGAGGAGAAGAGGAAAGAGA, reverse: TTGAGGACC-
TCTGTGTATTTGTCAA. The primer efficiency was determined and taken into
account when evaluating the qRT-PCR data. The data was normalised to the
geometrical mean of two housekeeping genes (GAPDH and RPLI3A) and the Pfaffl
method37 was used to analyse the qRT-PCR data.
SDS-PAGE and immunoblotting. Reduced protein extracts (20 mg protein)
were separated on 10% SDS-PAGE gels by electrophoresis and transferred to
polyvinylidene fluoride membranes (Millipore). Membranes were blocked in 5%
(w/v) non-fat milk in TBS-T (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.2%
Tween-20), incubated overnight at 4 uC in 5% milk-TBS-T or 3% BSA-TBS-T with
the appropriate primary antibodies. After 3 x 10 min washes in TBS-T, membranes
were incubated in horseradish peroxidase (HRP)-conjugated secondary antibodies
diluted in 5%milk-TBS-T for 45 min at room temperature and washed further 3 x 10
min in TBS-T. Detection was performed by ECL luminescence (Thermo Scientific).
The antibodies against phospho-Ser465/467 SMAD2 (#3101), total SMAD2/3
(#8658), SMAD4 (#9515), phospho-GSK3a/b (S21/9) (#9331) and GAPDH (#2118)
were purchased from Cell Signaling. Anti-PAI-1 (ab66705) was from Abcam. Anti-
TGFbR2 (sc-17792) was from Santa Cruz. Anti-Flag-M2 HRP (A8592) was from
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Sigma-Aldrich. Anti-tubulin (DM1A) was from Calbiochem. The anti-GFP and total
anti-GSK3a/b antibodies were raised in sheep using recombinant proteins as antigen
and affinity purified. Primary antibodies were used at 1:1000 dilution, except
GAPDH, which was used at 1:5000 dilution. HRP-coupled secondary antibodies
(1:5000) were obtained from Pierce.
Southern blotting. Genomic DNA of U2OS SEC-C cell and TGFb 2G Reporter
clone-17 were isolated using DNeasy kit (Qiagen). 8 mg genomic DNA was digested
with EcoR1 and separeted in a 1% agarose gel using a DNA molecular weight
Digoxigenin-labeled (Roche). DNA was transfered to Hybond-N1 membrane
(Amersham) in 10xSSC. Hybridization (50.8uC) and detection was perfomed
according to manufacturer’s instructions in DIG Easy Hyb Kit (Roche) and DIG
DNA detection Kit (Roche), respectivaly.
Statistical analysis. All experiments have a minimum of three biological replicates.
qRT-PCR experiments additionally have four technical repeats for each biological
replicate. Data are presented as the mean with error bars indicating the standard
deviation. Statistical significance of differences between experimental groups was
assessed with Student’s t-test. Differences in means were considered significant if
p,0.05. All Western blots shown are representatives.
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